Dealmakers are stepping in to consolidate the pharmaceutical supply chain just as Big Tech earnings take over the tape. KKR and Curium announced massive acquisitions Monday, contrasting with a blocked AstraZeneca-Bristol Myers megamerger, while Palantir's blowout results and SpaceX's looming lock-up expiration set the tone for a volatile week.
The pharmaceutical and medtech sectors saw a flurry of deal activity on Monday. Private equity firm KKR announced a $5.7 billion take-private deal for Integer Holdings, while radiopharmaceutical company Curium unveiled an $8 billion acquisition of Lantheus Holdings. Separately, reports emerged that a potential $400 billion megamerger between AstraZeneca and Bristol Myers Squibb was blocked, sending AstraZeneca shares down 7%.
Why it matters
This surge of M&A activity highlights the intense pressure on pharmaceutical companies to address upcoming patent cliffs and bolster pipelines. The combination of a successful take-private, a major strategic consolidation in the radiopharma space, and the failure of a megadeal points to a market prioritizing targeted, mid-size transactions over massive, complex integrations that face higher regulatory risk. This trend will continue to create catalyst-driven trading opportunities across the sector.
Eli Lilly (LLY) received two positive updates on Tuesday. The FDA granted Breakthrough Therapy designation to its cancer drug olomorasib for treating advanced pancreatic cancer with specific KRAS mutations, potentially accelerating its review. Separately, the company announced it will provide limited early access to its next-generation experimental obesity drug, retatrutide, ahead of a potential FDA approval, signaling high confidence in the therapy.
Why it matters
These developments reinforce the strength of Lilly's pipeline in both oncology and metabolic disease. The Breakthrough designation for olomorasib highlights a potentially accelerated path to market in a high-unmet-need cancer. The early access program for retatrutide is a strategic move to build physician and patient familiarity, aiming to solidify Lilly's dominance in the lucrative obesity market. Both are positive catalysts for the stock.
Palantir (PLTR) shares jumped nearly 15% in after-hours trading on Tuesday after the company reported Q2 results that blew past Wall Street estimates. Revenue grew 93% year-over-year to $1.935 billion, well ahead of the ~$1.81B consensus. The company posted a GAAP net income of $1.06 billion and raised its full-year revenue guidance by about $500 million, citing a 149% surge in U.S. commercial revenue.
Why it matters
This is a significant upside surprise that validates the enterprise AI demand thesis. The explosive growth in the U.S. commercial segment, a key focus for investors, suggests Palantir's strategy of operationalizing AI for corporations is gaining serious traction. The strong guidance provides a clear catalyst for a potential re-rating, setting the stock up for a continuation move and providing a positive read-through for other enterprise software names with AI exposure.
As the massive $99 billion SpaceX lock-up expiration we've been tracking approaches on August 6, the company is set to report its first-ever public quarterly results after Tuesday's close. With the stock hovering near the $108 level we noted previously, options are pricing in a significant move and shares saw a modest climb in pre-market trading.
Why it matters
This is a high-stakes, binary event for SpaceX. The inaugural earnings will provide the first real look at financials, particularly Starlink subscriber growth, cash flow, and capital burn. The results will set the tone for how the market absorbs the massive supply of shares hitting post-lock-up, creating a high-volatility setup. A beat could trigger a short squeeze, while a miss could see the stock break below the psychological $100 level.
Advanced Micro Devices (AMD) is set to report Q2 earnings after Tuesday's close, with options pricing in an 8.7% move. Analyst focus is squarely on the company's guidance for AI-related revenue. Key metrics to watch include the ramp of MI350 accelerator shipments, quantifiable orders for the new Helios rack-scale systems, and gross margin trends. The stock gained 3% overnight amid institutional buying ahead of the print.
Why it matters
This earnings report is a critical test of AMD's AI growth narrative. After a recent pullback, the market requires concrete evidence that AMD is gaining traction against Nvidia. Strong guidance on AI chip sales and initial orders for the full Helios system are necessary to justify its valuation and trigger a move back towards its highs. A weak outlook could cause a significant sell-off and raise questions about the competitive landscape.
Atkore Inc. (ATKR) shares surged over 28% on Tuesday, staging a classic episodic pivot. The catalyst was a dual announcement: a strong Q3 earnings beat and a definitive agreement to be acquired by Italian cable maker Prysmian for $95 per share. The stock opened with a textbook breakaway gap on volume 11 times its 20-day average, trading near its 52-week high.
Why it matters
This is a clean example of a catalyst-driven breakout merging with an M&A event. For traders, the initial move offered a powerful momentum opportunity. The deal now puts a ceiling on the price near the $95 acquisition target, shifting the play towards merger arbitrage. The extraordinary volume confirms massive institutional participation in the event.
Confirming the AI capital rotation into power grids we tracked recently, Eaton Corporation (ETN) shares jumped 4.86% on Monday after reporting a strong Q2 earnings beat. The company highlighted accelerating demand for its power management solutions from the AI data center market, prompting several analyst upgrades and driving the stock out of a multi-week base on high volume.
Why it matters
Eaton's report confirms the rotation of AI investment into physical infrastructure. The company's earnings and commentary provide concrete evidence that the demand for power solutions is a primary, monetizable theme. The stock's breakout on a fundamental catalyst makes this a classic episodic pivot, signaling institutional sponsorship and providing a clear long setup for traders playing the second-derivative AI theme.
Technical screening service ChartMill has flagged two regional bank stocks, US Bancorp (USB) and First Horizon (FHN), as having high-quality breakout setups. USB shows a perfect 10/10 technical rating and is trading near its 52-week high, outperforming 87% of stocks. FHN has a 9/10 setup quality score, trading in a tight consolidation near the top of its recent range with both short and long-term trends positive.
Why it matters
These stocks represent clean technical setups in a sector that has been consolidating. The high technical and setup scores from a systematic scanner provide objective confirmation of strong momentum and a well-defined risk/reward profile. For traders using a Stockbee or Kullamägi framework, these are actionable long candidates with clear consolidation patterns and invalidation levels.
Following up on the recent additions to Goldman's European and APAC conviction lists we covered, the firm has updated its influential U.S. Conviction List. On Monday, Goldman added Microsoft (MSFT), Applied Materials (AMAT), Delta Air Lines (DAL), O’Reilly Automotive (ORLY), UPS (UPS), and Viking Holdings (VIK), while removing Broadcom and ServiceNow.
Why it matters
Additions to the Goldman Conviction list are a strong institutional signal and often act as a catalyst for the named stocks. This refresh provides a tactical roadmap to where a major desk sees alpha, highlighting a rotation towards themes like AI software monetization (MSFT), cyclical recovery (DAL), and industrial logic (UPS), rather than just pure-play AI hardware. This is actionable intelligence for identifying potential new leadership.
Sell-side analysts are sharply divided on Circle (CRCL) ahead of its Q2 earnings. On Monday, Morgan Stanley reiterated an 'Underweight' rating with a $38 price target, citing shrinking USDC circulation and a shift to lower-margin revenue. In contrast, on Tuesday, TD Cowen initiated with a 'Buy' and an $82 target, while Bernstein maintained its 'Outperform' at $140, focusing on the company's evolution into a fee-based platform.
Why it matters
This extreme divergence in analyst ratings from major firms creates significant uncertainty and a potential volatility setup around the upcoming earnings report. The bull vs. bear debate centers on whether Circle's transaction-fee business can offset declining interest income from its reserves. The earnings call will be critical in validating one of these opposing theses, presenting a clear catalyst for a sharp move.
Following the sharp sell-off and V-shaped reversal in South Korean markets we noted recently, Morgan Stanley has officially upgraded the country's equities to 'Overweight' from 'Equalweight'. The firm set a Kospi target of 9,000—implying 36% upside—arguing the recent 30%+ correction was a technical 'leverage washout' rather than a fundamental breakdown, pointing to valuation support from key semiconductor names like Samsung and SK Hynix.
Why it matters
This is a significant contrarian call from a major institution. If Morgan Stanley is right, the AI hardware capex cycle remains strong, and the dislocation in Korean chip stocks represents a major buying opportunity. The upgrade provides an institutional anchor for a potential mean-reversion trade in the beaten-down semiconductor sector, with a specific focus on Korean memory makers.
The rotation of AI investment into physical infrastructure that we've been following is now moving even further down the stack into energy generation and raw materials. Two early-stage startups—Valar Atomics (small-modular nuclear reactors) and Mariana Minerals (critical minerals mining)—recently secured large funding rounds from prominent AI investors, according to a report from The Deep View.
Why it matters
This indicates a growing recognition that the primary constraints on AI's growth are no longer just compute, but power and materials. The smart money is front-running the massive future demand for electricity and specialized minerals required for the AI buildout. For traders, this flags nuclear energy, utilities, and mining as crucial second and third-derivative plays on the AI theme.
Following the hawkish dissent at the July FOMC meeting we tracked—where three members notably voted for a rate hike—Friday's July jobs report is shaping up to be a critical macro catalyst. Market consensus expects a rebound to 85,000-91,000 new jobs from June's weak 57,000 print, an outcome that could significantly increase the probability of a September or November rate increase.
Why it matters
With the Fed now highly data-dependent and refraining from strong forward guidance, this NFP report is a pivotal event. The outcome will directly influence rate expectations, with a strong print likely tightening financial conditions and strengthening the dollar, while a weak report could provide relief to rate-sensitive assets. This sets up a tradable event where the deviation from consensus will matter most.
Pharma and Medtech M&A Heats Up A wave of dealmaking is hitting the healthcare sector. KKR is taking Integer Holdings private for $5.7B and Curium is acquiring Lantheus for $8B, creating a new radiopharma giant. Meanwhile, a rumored $400B megamerger between AstraZeneca and Bristol Myers Squibb has reportedly been blocked, highlighting both the intense pressure to consolidate and the significant regulatory hurdles.
Palantir's Blowout Quarter Drives AI Stocks Higher Palantir surged nearly 15% after crushing Q2 estimates with a 93% revenue jump and raising full-year guidance. The strong results, driven by a 149% surge in U.S. commercial revenue, provided a significant boost to sentiment for enterprise AI software and lifted tech futures.
SpaceX Faces First Public Earnings Test Today marks a critical milestone for SpaceX as it delivers its first-ever quarterly report as a public company. With the stock trading near its lows and a 900-million-share lock-up expiring in two days, the release will be a major volatility event. All eyes are on Starlink subscriber numbers, capital burn, and overall profitability.
Goldman Sachs Conviction List Signals Market Broadening Goldman's latest Conviction List update suggests a strategic rotation beyond mega-cap tech concentration. By adding names like Microsoft, Applied Materials, Delta, UPS, and O'Reilly, the bank is signaling a belief in a broadening market, with a focus on company-specific catalysts in software, cyclicals, and industrials.
AI Infrastructure Investment Moves Down the Stack Venture capital from prominent AI investors is now flowing into foundational infrastructure beyond chips. Recent significant funding rounds for a small-modular nuclear reactor startup (Valar Atomics) and a critical minerals miner (Mariana Minerals) signal a recognition that energy and raw materials are the new bottlenecks for scaling AI.
What to Expect
2026-08-04—AMD, Lucid, and Kratos Defense report earnings after market close.
2026-08-06—SpaceX insider lock-up expiration releases over 900 million shares. Applied Optoelectronics (AAOI) and B3 (B3SA3) report earnings.
2026-08-07—July Non-Farm Payrolls (NFP) report to be released, a key data point for the Fed's September rate decision.
August 2026—FDA PDUFA dates for Moderna, Lantheus, Bristol Myers Squibb, Capricor, and Ultragenyx.
How We Built This Briefing
Every story, researched.
Every story verified across multiple sources before publication.
🔍
Scanned
Across multiple search engines and news databases
604
📖
Read in full
Every article opened, read, and evaluated
176
⭐
Published today
Ranked by importance and verified across sources
13
— The Tape Reader
🎙 Listen as a podcast
Subscribe in your favorite podcast app to get each new briefing delivered automatically as audio.
Apple Podcasts
Library tab → ••• menu → Follow a Show by URL → paste